700
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Synthesis of purine homo-N-nucleosides modified with coumarins as free radicals scavengers*

, &
Pages 765-775 | Received 28 Jan 2012, Accepted 29 Mar 2012, Published online: 16 May 2012

References

  • De Clercq E. Highlights in the discovery of antiviral drugs: a personal retrospective. J Med Chem 2010;53:1438–1450.
  • Mehellou Y, De Clercq E. Twenty-six years of anti-HIV drug discovery: where do we stand and where do we go? J Med Chem 2010;53:521–538.
  • De Clercq E. New approaches toward anti-HIV chemotherapy. J Med Chem 2005;48:1297–1313.
  • De Clercq E. Acyclic nucleoside phosphonates: past, present and future. Bridging chemistry to HIV, HBV, HCV, HPV, adeno-, herpes-, and poxvirus infections: the phosphonate bridge. Biochem Pharmacol 2007;73:911–922.
  • De Clercq E. The acyclic nucleoside phosphonates from inception to clinical use: historical perspective. Antiviral Res 2007;75:1–13.
  • Herdewijn P (2008). In Modified Nucleosides in Biochemistry, Biotechnology and Medicine. Weinheim, Germany: Wiley-VCH.
  • Parker WB. Enzymology of purine and pyrimidine antimetabolites used in the treatment of cancer. Chem Rev 2009;109:2880–2893.
  • Mieczkowski A, Roy V, Agrofoglio LA. Preparation of cyclonucleosides. Chem Rev 2010;110:1828–1856.
  • Matsuda A, Sasaki T. Antitumor activity of sugar-modified cytosine nucleosides. Cancer Sci 2004;95:105–111.
  • Wang Y, Shakespeare WC, Huang WS, Sundaramoorthi R, Lentini S, Das S et al. Novel N9-arenethenyl purines as potent dual Src/Abl tyrosine kinase inhibitors. Bioorg Med Chem Lett 2008;18:4907–4912.
  • Levy D, Marlowe C, Kane-Maguire K, Bao M, Cherbavaz D, Tomlinson J et al. Hydroxamate based inhibitors of adenylyl cyclase. Part 1: the effect of acyclic linkers on P-site binding. Bioorg Med Chem Lett 2002;12:3085–3088.
  • Spanou C, Manta S, Komiotis D, Dervishi A, Kouretas D. Antioxidant activity of a series of fluorinated pyrano-nucleoside analogues of N4-benzoyl cytosine and N6-benzoyl adenine. Int J Mol Sci 2007; 8:625–704.
  • Οtt H.(1989) US Patent 4.849.423.
  • O’Kennedy R, Thornes RD. (1997) “Coumarins: biology, applications and mode of action”. Chichester: J. Wiley & Sons.
  • Murray DH, Mendez J, Brown SA. (1982) “The natural coumarins: occurrence, chemistry and biochemistry”. N. York: J. Wiley & Sons.
  • Fylaktakidou KC, Hadjipavlou-Litina DJ, Litinas KE, Nicolaides DN. Natural and synthetic coumarin derivatives with anti-inflammatory/ antioxidant activities. Curr Pharm Des 2004;10:3813–3833.
  • Borges F, Roleira F, Milhazes N, Santana L, Uriarte E. Simple coumarins and analogues in medicinal chemistry: occurrence, synthesis and biological activity. Curr Med Chem 2005;12:887–916.
  • Lacy A, O’Kennedy R. Studies on coumarins and coumarin-related compounds to determine their therapeutic role in the treatment of cancer. Curr Pharm Des 2004;10:3797–3811.
  • Kostova I. Synthetic and natural coumarins as antioxidants. Mini Rev Med Chem 2006;6:365–374.
  • Chimichi S, Boccalini M, Cravotto G, Rosati O. A new convenient route to enantiopure 2-coumarinyloxypropanals: application to the synthesis of optically active geiparvarin analogues. Tetrahedron Lett 2006; 47:2405–2408.
  • Viola G, Vedaldi D, dall’Acqua F, Basso G, Disarò S, Spinelli M et al. Synthesis, cytotoxicity, and apoptosis induction in human tumor cells by geiparvarin analogues. Chem Biodivers 2004;1:1265–1280.
  • Carotti A, Carrieri A, Chimichi S, Boccalini M, Cosimelli B, Gnerre C et al. Natural and synthetic geiparvarins are strong and selective MAO-B inhibitors. Synthesis and SAR studies. Bioorg Med Chem Lett 2002;12:3551–3555.
  • Curini M, Cravotto G, Epifano F, Giannone G. Chemistry and biological activity of natural and synthetic prenyloxycoumarins. Curr Med Chem 2006;13:199–222.
  • Nicolaides DN, Gautam DR, Litinas KE, Hadjipavlou-Litina DJ, Fylaktakidou KC. Synthesis and evaluation of the antioxidant and antiinflammatory activities of some benzo[l]khellactone derivatives and analogues. Eur J Med Chem 2004;39: 323–332.
  • Galariniotou E, Fragos V, Makri A, Litinas KE, Nicolaides DN. Synthesis of novel pyridocoumarins and benzo-fused 6-azacoumarins. Tetrahedron 2007; 63:8298–8304.
  • Baldoumi V, Gautam DR, Litinas KE, Nicolaides DN. Convenient synthesis of linear pyrano[3,2-g]-, [2,3-g]- and angular pyrano[3,2-f]coumarins from 4[(1,1-dimethyl-2-propynyl)oxy]phenol. Tetrahedron 2006; 62:8016–8020.
  • Gautam DR, Protopapas J, Fylaktakidou KC, Litinas KE, Nicolaides DN, Tsoleridis K. Unexpected one-pot synthesis of new polyclic coumarin[4,3-c]pyridine derivatives via a tandem hetero Diels-Alder and 1,3-dipolar cycloaddition reaction. Tetrahedron Lett 2009; 50:448–451.
  • Kontogiorgis C, Litinas KE, Makri A, Nicolaides DN, Vronteli A, Hadjipavlou-Litina DJ et al. Synthesis and biological evaluation of novel angular fused Pyrrolocoumarins. J Enzyme Inhib Med Chem 2008;23:43–49.
  • Symeonidis T, Chamilos M, Hadjipavlou-Litina DJ, Kallitsakis M, Litinas KE. Synthesis of hydroxycoumarins and hydroxybenzo[f]- or [h]coumarins as lipid peroxidation inhibitors. Bioorg Med Chem Lett 2009;19:1139–1142.
  • Thalassitis A, Hadjipavlou-Litina DJ, Litinas KE, Miltiadou P. Synthesis of modified homo-N-nucleosides from the reactions of mesityl nitrile oxide with 9-allylpurines and their influence on lipid peroxidation and thrombin inhibition. Bioorg Med Chem Lett 2009;19:6433–6436.
  • Litinas KE, Thalassitis A. Synthesis of fused dihydropyrido[e]purines via ring closing metathesis. Tetrahedron Lett 2010; 51:6451–6453.
  • Merlini PA, Cugno M, Rossi ML, Agricola P, Repetto A, Fetiveau R et al. Activation of the contact system and inflammation after thrombolytic therapy in patients with acute myocardial infarction. Am J Cardiol 2004;93:822–825.
  • Maraganore JM. Thrombin, thrombin inhibitors, and the arterial thrombotic process. Thromb Haemost 1993;70:208–211.
  • Vougioukalakis GC, Grubbs RH. Ruthenium-based heterocyclic carbene-coordinated olefin metathesis catalysts. Chem Rev 2010;110:1746–1787.
  • Grubbs RH. Olefin metathesis. Tetrahedron 2004; 60:7117–7140
  • Schrock RR, Hoveyda AH. Molybdenum and tungsten imido alkylidene complexes as efficient olefin-metathesis catalysts. Angew Chem Int Ed Engl 2003;42:4592–4633.
  • Grubbs, RH. (2003) In Handbook of Metathesis. Weinheim, Germany: Wiley-VCH.
  • Hoveyda AH, Gillingham DG, Van Veldhuizen JJ, Kataoka O, Garber SB, Kingsbury JS et al. Ru complexes bearing bidentate carbenes: from innocent curiosity to uniquely effective catalysts for olefin metathesis. Org Biomol Chem 2004;2:8–23.
  • Chatterjee AK, Choi TL, Sanders DP, Grubbs RH. A general model for selectivity in olefin cross metathesis. J Am Chem Soc 2003;125:11360–11370.
  • Connon SJ, Blechert S. Recent developments in olefin cross-metathesis. Angew Chem Int Ed Engl 2003;42:1900–1923.
  • Amblard F, Nolan SP, Agrofoglio LA. Metathesis strategy in nucleoside chemistry. Tetrahedron 2005; 61:7067–7080.
  • Amblard F, Nolan SP, Gillaizeau I, Agrofoglio LA. A new route to acyclic nucleosides via palladium-mediated allylic alkylation and cross-metathesis. Tetrahedron Lett 2003; 44:9177–9180
  • Amblard F, Nolan SP, Schinazi RF, Agrofoglio LA. Efficient synthesis of various acycloalkenyl derivatives of pyrimidine using cross-metathesis and Pd(0) methodologies. Tetrahedron 2005; 61:537–544.
  • Zhong S, Mondon M, Pilasrd S, Len C. Synthesis of novel dinucleosides via tandem cross-metathesis and ring-closing metathesis. Tetrahedron Lett 2006; 47:6221–6224
  • Roy V, Zerrouki R, Krausz P. New dinucleoside analogues via cross-coupling metathesis. Nucleosides Nucleotides Nucleic Acids 2005;24:289–301.
  • Murata S, Ichikawa S, Matsuda A. Synthesis of galactose-linked uridine derivatives with simple linkers as potential galactosyltransferase inhibitors. Tetrahedron 2005; 61: 5837–5842
  • Batoux N, Benhaddou-Zerrouki R, Bressolier P, Granet R, Laumont G, Aubertin AM, Krausz P. Nucleoside homodimerisation by cross metathesis. Tetrahedron Lett 2001; 42:1491–1493.
  • Colombeau L, Zerrouki R, Krausz P, Champavier Y. Dinucleoside analog synthesis via microwave activated cross coupling metathesis. Lett Org Chem 2005; 2:613–615.
  • Coquerel Y, Rodriguez J. Microwave-assisted olefin metathesis. Eur J Org Chem 2008; 1125–1132
  • Gebauer J, Arseniyadis S, Cossy J. Total synthesis of cystothiazole A by microwave-assisted olefin cross-metathesis. Eur J Org Chem 2008; 2701–2704
  • Fustero S, Jiménez D, Sanchez-Roselló M, del Pozo C. Microwave-assisted tandem cross metathesis intramolecular Aza-Michael reaction: an easy entry to cyclic beta-amino carbonyl derivatives. J Am Chem Soc 2007;129:6700–6701.
  • Jackson S, Nieduzak T, Rebello S, Liang G, Chiang Y, Merrill J. Coumarins as iNOS inhibitors. 2005; US Patent 20050054681 A1.
  • Avetisyan AA, Alvandzhyan AG. Syntheses on the basis of 2H-chromen-2-one and 2H-chromen-2-thione. Russ J Org Chem (Engl Transl) 2006; 42:1063–1067.
  • Kaufman KD, Keana JFW, Kelly RC, McBride DW, Slomp G. Synthetic furocoumarins. VI analogs of psoralene derived from hydroquinone. J Org Chem 1962; 27:2567–2572.
  • Gundersen LL. Synthesis of purinecarbonitriles by Pd(0)-catalysed coupling of halopurines with Zinc cyanide. Acta Chem Scand 1996; 50:58–63.
  • Breitmaier E, Voelter W (1987). Carbon-13 NMR spectroscopy. High resolutions methods and applications in organic chemistry and biochemistry. New York: VCH, p. 192.
  • Chatterjee AK, Choi TL, Sanders DP, Grubbs RH. A general model for selectivity in olefin cross metathesis. J Am Chem Soc 2003; 125:11360–11370.
  • Pontiki E, Hadjipavlou-Litina D. Synthesis and pharmacochemical evaluation of novel aryl-acetic acid inhibitors of lipoxygenase, antioxidants, and anti-inflammatory agents. Bioorg Med Chem 2007;15:5819–5827.
  • Halliwell B Gutterridge JMC (1989) Editors, In Free Radicals in Biology and Medicine Oxford, UK Clarendon
  • Huang D, Ou B, Prior RL. The chemistry behind antioxidant capacity assays. J Agric Food Chem 2005;53:1841–1856.
  • Górnicki A, Gutsze A. In vivo and in vitro influence of etretinate on erythrocyte membrane fluidity. Eur J Pharmacol 2001;423: 127–134.
  • Liégeois C, Lermusieau G, Collin S. Measuring antioxidant efficiency of wort, malt, and hops against the 2,2′-azobis(2-amidinopropane) dihydrochloride-induced oxidation of an aqueous dispersion of linoleic acid. J Agric Food Chem 2000;48:1129–1134.
  • Taraporewala IB, Kauffman JM. Synthesis and structure-activity relationships of anti-inflammatory 9,10-dihydro-9-oxo-2-acridine-alkanoic acids and 4-(2-carboxyphenyl)aminobenzenealkanoic acids. J Pharm Sci 1990;79:173–178.
  • Müller K. 5-Lipoxygenase and 12-lipoxygenase: attractive targets for the development of novel antipsoriatic drugs. Arch Pharm (Weinheim) 1994;327:3–19.
  • Pontiki E Hadjipavlou-Litina D. Review in QSARs on LOX inhibitors.Mini Rev Med Chem 2003;3:487–499
  • Pontiki E, Hadjipavlou-Litina D. Lipoxygenase inhibitors: a comparative QSAR study review and evaluation of new QSARs. Med Res Rev 2008;28:39–117.
  • Biobyte Corp. C-QSAR Database 201 West 4th Str., Suite 204, Claremont CA, California 91711, USA.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.